메뉴 건너뛰기




Volumn 6, Issue , 2012, Pages 417-426

Effect of a continuous measure of adherence with infliximab maintenance treatment on inpatient outcomes in Crohn's disease

Author keywords

Costs; Crohn's disease; Hospitalization; Infliximab; Length of stay; Medication adherence

Indexed keywords

BIOLOGICAL PRODUCT; CORTICOSTEROID DERIVATIVE; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE;

EID: 84886063449     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S31115     Document Type: Article
Times cited : (21)

References (37)
  • 1
    • 0036161786 scopus 로고    scopus 로고
    • The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: A systematic review
    • Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16(1): 51-60.
    • (2002) Aliment Pharmacol Ther , vol.16 , Issue.1 , pp. 51-60
    • Loftus Jr., E.V.1    Schoenfeld, P.2    Sandborn, W.J.3
  • 2
    • 33751560242 scopus 로고    scopus 로고
    • Psychotherapy with chronic inflammatory bowel disease patients: A review
    • Von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis. 2006;12(12): 1175-1184.
    • (2006) Inflamm Bowel Dis , vol.12 , Issue.12 , pp. 1175-1184
    • von Wietersheim, J.1    Kessler, H.2
  • 3
    • 51449101025 scopus 로고    scopus 로고
    • Crohn's disease: Current treatment options
    • Akobeng AK. Crohn's disease: current treatment options. Arch Dis Child. 2008;93(9):787-792.
    • (2008) Arch Dis Child , vol.93 , Issue.9 , pp. 787-792
    • Akobeng, A.K.1
  • 4
    • 72549100736 scopus 로고    scopus 로고
    • Strategies to improve quality of life in adolescents with inflammatory bowel disease
    • Karwowski CA, Keljo D, Szigethy E. Strategies to improve quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(11):1755-1764.
    • (2009) Inflamm Bowel Dis , vol.15 , Issue.11 , pp. 1755-1764
    • Karwowski, C.A.1    Keljo, D.2    Szigethy, E.3
  • 5
    • 84876015508 scopus 로고    scopus 로고
    • Management of inflammatory bowel disease in adults
    • Katz JA. Management of inflammatory bowel disease in adults. J Dig Dis. 2007;8(2):65-71.
    • (2007) J Dig Dis , vol.8 , Issue.2 , pp. 65-71
    • Katz, J.A.1
  • 6
    • 57249103566 scopus 로고    scopus 로고
    • Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults
    • Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907-1913.
    • (2008) Gastroenterology , vol.135 , Issue.6 , pp. 1907-1913
    • Kappelman, M.D.1    Rifas-Shiman, S.L.2    Porter, C.Q.3
  • 7
    • 39749169727 scopus 로고    scopus 로고
    • The costs of Crohn's disease in the United States and other Western countries: A systematic review
    • Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J. The costs of Crohn's disease in the United States and other Western countries: a systematic review. Curr Med Res Opin. 2008;24(2):319-328.
    • (2008) Curr Med Res Opin , vol.24 , Issue.2 , pp. 319-328
    • Yu, A.P.1    Cabanilla, L.A.2    Wu, E.Q.3    Mulani, P.M.4    Chao, J.5
  • 8
    • 70949107842 scopus 로고    scopus 로고
    • Inflammatory bowel disease
    • Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009; 361(21):2066-2078.
    • (2009) N Engl J Med , vol.361 , Issue.21 , pp. 2066-2078
    • Abraham, C.1    Cho, J.H.2
  • 9
    • 0030954732 scopus 로고    scopus 로고
    • A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
    • the Crohn's Disease cA2 Study Group
    • Targan SR, Hanauer SB, van Deventer SJH, et al; the Crohn's Disease cA2 Study Group. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med. 1997;337(15):1029-1035.
    • (1997) N Engl J Med , vol.337 , Issue.15 , pp. 1029-1035
    • Targan, S.R.1    Hanauer, S.B.2    van Deventer, S.J.H.3
  • 10
    • 0037018761 scopus 로고    scopus 로고
    • Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
    • and the ACCENT I Study Group
    • Hanauer SB, Feagan BG, Lichtenstein GR, et al; and the ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002:359(9317):1541-1549.
    • (2002) Lancet , vol.359 , Issue.9317 , pp. 1541-1549
    • Hanauer, S.B.1    Feagan, B.G.2    Lichtenstein, G.R.3
  • 11
    • 10744221312 scopus 로고    scopus 로고
    • Infliximab maintenance therapy for fistulizing Crohn's disease
    • Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350(9): 876-885.
    • (2004) N Engl J Med , vol.350 , Issue.9 , pp. 876-885
    • Sands, B.E.1    Anderson, F.H.2    Bernstein, C.N.3
  • 12
    • 0033529049 scopus 로고    scopus 로고
    • Infliximab for the treatment of fistulas in patients with Crohn's disease
    • Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340(18):1398-1405.
    • (1999) N Engl J Med , vol.340 , Issue.18 , pp. 1398-1405
    • Present, D.H.1    Rutgeerts, P.2    Targan, S.3
  • 13
    • 59749093368 scopus 로고    scopus 로고
    • Management of Crohn's disease in adults
    • and the Practice Parameters Committee of the American College of Gastroenterology
    • Lichtenstein GR, Hanauer SB, Sandborn WJ; and the Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2009;104(2):465-483.
    • (2009) Am J Gastroenterol , vol.104 , Issue.2 , pp. 465-483
    • Lichtenstein, G.R.1    Hanauer, S.B.2    Sandborn, W.J.3
  • 14
    • 17144388945 scopus 로고    scopus 로고
    • Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease
    • Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005; 128(4):862-869.
    • (2005) Gastroenterology , vol.128 , Issue.4 , pp. 862-869
    • Lichtenstein, G.R.1    Yan, S.2    Bala, M.3    Blank, M.4    Sands, B.E.5
  • 15
    • 84886014245 scopus 로고    scopus 로고
    • Infliximab (Remicade) treatment results in lower hospitalization rate in Crohn's disease patients
    • Poster presented at, May 19-22, San Francisco, CA
    • Colombel JF, Rutgeerts P, Yan S, et al. Infliximab (Remicade) treatment results in lower hospitalization rate in Crohn's disease patients. Poster presented at Digestive Disease Week, May 19-22, 2002, San Francisco, CA.
    • (2002) Digestive Disease Week
    • Colombel, J.F.1    Rutgeerts, P.2    Yan, S.3
  • 16
    • 82455188426 scopus 로고    scopus 로고
    • Long-term infliximab maintenance infusion regimens and rates of hospitalization, surgery and disability in Crohn's disease patients [Abstract]
    • A-589
    • Williams JB, Cross RK, Thameen D, et al. Long-term infliximab maintenance infusion regimens and rates of hospitalization, surgery and disability in Crohn's disease patients [Abstract]. Gastroenterology. 2005;128(4 Suppl 2):A-589.
    • (2005) Gastroenterology , vol.128 , Issue.4 SUPPL. 2
    • Williams, J.B.1    Cross, R.K.2    Thameen, D.3
  • 17
    • 73949129079 scopus 로고    scopus 로고
    • Long-term infliximab maintenance infusion regimens and rates of hospitalization, surgery, and disability in Crohn's disease [Abstract]
    • A-143
    • Williams JB, Weber LR, Beaulieu DB, et al. Long-term infliximab maintenance infusion regimens and rates of hospitalization, surgery, and disability in Crohn's disease [Abstract]. Gastroenterology. 2006;130(4 Suppl 2):A-143.
    • (2006) Gastroenterology , vol.130 , Issue.4 SUPPL. 2
    • Williams, J.B.1    Weber, L.R.2    Beaulieu, D.B.3
  • 18
    • 63849101007 scopus 로고    scopus 로고
    • Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: Results from a single-centre cohort
    • Schnitzler F, Fidder H, Ferrante M, et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut. 2009;58(4):492-500.
    • (2009) Gut , vol.58 , Issue.4 , pp. 492-500
    • Schnitzler, F.1    Fidder, H.2    Ferrante, M.3
  • 19
    • 10744224387 scopus 로고    scopus 로고
    • Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
    • Rutgeerts P, Feagan BG, Lichtenstein GR, et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology. 2004;126(2):402-413.
    • (2004) Gastroenterology , vol.126 , Issue.2 , pp. 402-413
    • Rutgeerts, P.1    Feagan, B.G.2    Lichtenstein, G.R.3
  • 20
    • 79956102354 scopus 로고    scopus 로고
    • PharMetrics Inc, Watertown, MA: IMS Health
    • PharMetrics Inc. LifeLink Health Plan Claims Database. Watertown, MA: IMS Health; 2010.
    • (2010) LifeLink Health Plan Claims Database
  • 21
    • 0036719562 scopus 로고    scopus 로고
    • Patient adherence and medical treatment outcomes: A meta-analysis
    • DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811.
    • (2002) Med Care , vol.40 , Issue.9 , pp. 794-811
    • DiMatteo, M.R.1    Giordani, P.J.2    Lepper, H.S.3    Croghan, T.W.4
  • 22
    • 1642397582 scopus 로고    scopus 로고
    • Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research
    • DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209.
    • (2004) Med Care , vol.42 , Issue.3 , pp. 200-209
    • DiMatteo, M.R.1
  • 23
    • 34250804375 scopus 로고    scopus 로고
    • Adherence to thiopurine treatment in out-patients with Crohn's disease
    • Bokemeyer B, Teml A, Roggel C, et al. Adherence to thiopurine treatment in out-patients with Crohn's disease. Aliment Pharmacol Ther. 2007;26(2):217-225.
    • (2007) Aliment Pharmacol Ther , vol.26 , Issue.2 , pp. 217-225
    • Bokemeyer, B.1    Teml, A.2    Roggel, C.3
  • 24
    • 34247597731 scopus 로고    scopus 로고
    • How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission?
    • Mantzaris GJ, Roussos A, Kalantzis C, Koilakou S, Raptis N, Kalantzis N. How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission? Inflamm Bowel Dis. 2007;13(4):446-450.
    • (2007) Inflamm Bowel Dis , vol.13 , Issue.4 , pp. 446-450
    • Mantzaris, G.J.1    Roussos, A.2    Kalantzis, C.3    Koilakou, S.4    Raptis, N.5    Kalantzis, N.6
  • 25
    • 33845197193 scopus 로고    scopus 로고
    • Persistence with pharmacotherapy for gastrointestinal disease: Associated costs of health care
    • Shaya FT, El Khoury AC, Wong W, et al. Persistence with pharmacotherapy for gastrointestinal disease: associated costs of health care. PT. 2006;31(11):657-665.
    • (2006) PT , vol.31 , Issue.11 , pp. 657-665
    • Shaya, F.T.1    El Khoury, A.C.2    Wong, W.3
  • 26
    • 58149094256 scopus 로고    scopus 로고
    • Systematic review: Impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares
    • Higgins PD, Rubin DT, Kaulback K, Schoenfield PS, Kane SV. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009;29(3):247-257.
    • (2009) Aliment Pharmacol Ther , vol.29 , Issue.3 , pp. 247-257
    • Higgins, P.D.1    Rubin, D.T.2    Kaulback, K.3    Schoenfield, P.S.4    Kane, S.V.5
  • 27
    • 40749086101 scopus 로고    scopus 로고
    • Medication non-adherence is associated with increased medical health care costs
    • Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008;53(4):1020-1024.
    • (2008) Dig Dis Sci , vol.53 , Issue.4 , pp. 1020-1024
    • Kane, S.1    Shaya, F.2
  • 28
    • 77949265473 scopus 로고    scopus 로고
    • Factors associated with non-adherence to oral medication for inflammatory bowel disease: A systematic review
    • Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2010;105(3):525-539.
    • (2010) Am J Gastroenterol , vol.105 , Issue.3 , pp. 525-539
    • Jackson, C.A.1    Clatworthy, J.2    Robinson, A.3    Horne, R.4
  • 29
    • 73949091371 scopus 로고    scopus 로고
    • Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients
    • Kane SV, Chao J, Mulani PM. Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients. Adv Ther. 2009;26(10):936-946.
    • (2009) Adv Ther , vol.26 , Issue.10 , pp. 936-946
    • Kane, S.V.1    Chao, J.2    Mulani, P.M.3
  • 30
    • 48549099538 scopus 로고    scopus 로고
    • Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis
    • Tang B, Rahman M, Waters HC, Callegari P. Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis. Clin Ther. 2008;30(7):1375-1384.
    • (2008) Clin Ther , vol.30 , Issue.7 , pp. 1375-1384
    • Tang, B.1    Rahman, M.2    Waters, H.C.3    Callegari, P.4
  • 32
    • 0030730033 scopus 로고    scopus 로고
    • Inflammatory bowel disease: Health care and costs in Sweden in 1994
    • Blomqvist P, Ekbom A. Inflammatory bowel disease: health care and costs in Sweden in 1994. Scand J Gastroenterol. 1997;32(11):1134-1139.
    • (1997) Scand J Gastroenterol , vol.32 , Issue.11 , pp. 1134-1139
    • Blomqvist, P.1    Ekbom, A.2
  • 33
    • 0033993951 scopus 로고    scopus 로고
    • Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital
    • Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastreoenterol. 2000;95(3):677-683.
    • (2000) Am J Gastreoenterol , vol.95 , Issue.3 , pp. 677-683
    • Bernstein, C.N.1    Papineau, N.2    Zajaczkowski, J.3    Rawsthorne, P.4    Okrusko, G.5    Blanchard, J.F.6
  • 34
    • 38049064973 scopus 로고    scopus 로고
    • Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004
    • Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007;13(12):1529-1535.
    • (2007) Inflamm Bowel Dis , vol.13 , Issue.12 , pp. 1529-1535
    • Nguyen, G.C.1    Tuskey, A.2    Dassopoulos, T.3    Harris, M.L.4    Brant, S.R.5
  • 35
    • 4644366980 scopus 로고    scopus 로고
    • Cost-of-illness of inflammatory bowel disease in the United Kingdom: A single-centre retrospective study
    • Bassi A, Dodd S, Williamson P, Bodger K. Cost-of-illness of inflammatory bowel disease in the United Kingdom: a single-centre retrospective study. Gut. 2004;53(10):1471-1478.
    • (2004) Gut , vol.53 , Issue.10 , pp. 1471-1478
    • Bassi, A.1    Dodd, S.2    Williamson, P.3    Bodger, K.4
  • 36
    • 38549098101 scopus 로고    scopus 로고
    • Medication compliance and persistence: Terminology and definitions
    • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44-47.
    • (2008) Value Health , vol.11 , Issue.1 , pp. 44-47
    • Cramer, J.A.1    Roy, A.2    Burrell, A.3
  • 37
    • 77953713861 scopus 로고    scopus 로고
    • Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease
    • Stein DJ, Ananthakrishnan AN, Issa M, et al. Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease. Inflamm Bowel Dis. 2010;16(7): 1173-1179.
    • (2010) Inflamm Bowel Dis , vol.16 , Issue.7 , pp. 1173-1179
    • Stein, D.J.1    Ananthakrishnan, A.N.2    Issa, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.